Bank of America’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.15M | Sell |
425,701
-45,006
| -10% | -$227K | ﹤0.01% | 3962 |
|
2025
Q1 | $3.05M | Buy |
470,707
+277,057
| +143% | +$1.8M | ﹤0.01% | 3615 |
|
2024
Q4 | $1.42M | Sell |
193,650
-142,943
| -42% | -$1.05M | ﹤0.01% | 4001 |
|
2024
Q3 | $2.52M | Sell |
336,593
-515,181
| -60% | -$3.86M | ﹤0.01% | 3711 |
|
2024
Q2 | $7.58M | Sell |
851,774
-284,580
| -25% | -$2.53M | ﹤0.01% | 2769 |
|
2024
Q1 | $11.5M | Buy |
1,136,354
+984,009
| +646% | +$9.97M | ﹤0.01% | 2447 |
|
2023
Q4 | $1.53M | Sell |
152,345
-609,960
| -80% | -$6.14M | ﹤0.01% | 3823 |
|
2023
Q3 | $7.14M | Buy |
762,305
+421,403
| +124% | +$3.95M | ﹤0.01% | 2581 |
|
2023
Q2 | $8.36M | Sell |
340,902
-268,813
| -44% | -$6.59M | ﹤0.01% | 2442 |
|
2023
Q1 | $14.2M | Buy |
609,715
+99,862
| +20% | +$2.32M | ﹤0.01% | 2124 |
|
2022
Q4 | $12.9M | Buy |
509,853
+73,763
| +17% | +$1.87M | ﹤0.01% | 2070 |
|
2022
Q3 | $8.41M | Buy |
436,090
+239,146
| +121% | +$4.61M | ﹤0.01% | 2364 |
|
2022
Q2 | $5.02M | Sell |
196,944
-304,235
| -61% | -$7.75M | ﹤0.01% | 2927 |
|
2022
Q1 | $12.9M | Buy |
501,179
+197,274
| +65% | +$5.07M | ﹤0.01% | 2267 |
|
2021
Q4 | $12.7M | Buy |
303,905
+118,522
| +64% | +$4.96M | ﹤0.01% | 2310 |
|
2021
Q3 | $8.07M | Sell |
185,383
-48,291
| -21% | -$2.1M | ﹤0.01% | 2659 |
|
2021
Q2 | $11M | Buy |
233,674
+54,888
| +31% | +$2.6M | ﹤0.01% | 2378 |
|
2021
Q1 | $9.17M | Buy |
178,786
+132,998
| +290% | +$6.82M | ﹤0.01% | 2494 |
|
2020
Q4 | $1.23M | Buy |
45,788
+20,801
| +83% | +$557K | ﹤0.01% | 3725 |
|
2020
Q3 | $858K | Sell |
24,987
-21,369
| -46% | -$734K | ﹤0.01% | 3807 |
|
2020
Q2 | $1.9M | Buy |
46,356
+44,631
| +2,587% | +$1.83M | ﹤0.01% | 3267 |
|
2020
Q1 | $59K | Buy |
1,725
+609
| +55% | +$20.8K | ﹤0.01% | 5205 |
|
2019
Q4 | $14K | Buy |
+1,116
| New | +$14K | ﹤0.01% | 5742 |
|